CIBC World Market’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12.9M | Sell |
84,313
-444,250
| -84% | -$68.1M | 0.02% | 337 |
|
|
2025
Q4 | $72.9M | Buy |
528,563
+374,016
| +242% | +$49M | 0.12% | 119 |
|
|
2025
Q3 | $19.8M | Sell |
154,547
-4,451
| -3% | -$543K | 0.04% | 271 |
|
|
2025
Q2 | $19.2M | Sell |
158,998
-1,704,000
| -91% | -$192M | 0.04% | 261 |
|
|
2025
Q1 | $208M | Buy |
1,862,998
+1,813,497
| +3,664% | +$193M | 0.44% | 52 |
|
|
2024
Q4 | $4.82M | Buy |
49,501
+453
| +0.9% | +$48.3K | 0.01% | 524 |
|
|
2024
Q3 | $5.64M | Sell |
49,048
-209
| -0.4% | -$23.7K | 0.01% | 457 |
|
|
2024
Q2 | $5.24M | Sell |
49,257
-1,512
| -3% | -$152K | 0.01% | 434 |
|
|
2024
Q1 | $4.91M | Sell |
50,769
-2,411
| -5% | -$247K | 0.01% | 459 |
|
|
2023
Q4 | $5.37M | Sell |
53,180
-63,100
| -54% | -$6.09M | 0.01% | 393 |
|
|
2023
Q3 | $11.2M | Sell |
116,280
-14,270
| -11% | -$1.45M | 0.04% | 222 |
|
|
2023
Q2 | $13.2M | Buy |
130,550
+614
| +0.5% | +$61.4K | 0.04% | 215 |
|
|
2023
Q1 | $12M | Sell |
129,936
-1,642
| -1% | -$143K | 0.04% | 228 |
|
|
2022
Q4 | $11.9M | Buy |
131,578
+54
| +0% | +$4.55K | 0.04% | 231 |
|
|
2022
Q3 | $10M | Sell |
131,524
-3,852
| -3% | -$319K | 0.04% | 232 |
|
|
2022
Q2 | $11.4M | Sell |
135,376
-1,188
| -0.9% | -$104K | 0.04% | 219 |
|
|
2022
Q1 | $12M | Sell |
136,564
-12,093
| -8% | -$1.05M | 0.04% | 222 |
|
|
2021
Q4 | $13M | Buy |
148,657
+237
| +0.2% | +$19.7K | 0.04% | 224 |
|
|
2021
Q3 | $12.1M | Sell |
148,420
-918
| -0.6% | -$82.6K | 0.04% | 217 |
|
|
2021
Q2 | $13.6M | Buy |
149,338
+4,975
| +3% | +$443K | 0.04% | 216 |
|
|
2021
Q1 | $12.3M | Buy |
144,363
+4,096
| +3% | +$368K | 0.04% | 218 |
|
|
2020
Q4 | $13.2M | Buy |
140,267
+21,470
| +18% | +$1.88M | 0.04% | 206 |
|
|
2020
Q3 | $10.3M | Buy |
118,797
+8,538
| +8% | +$740K | 0.04% | 203 |
|
|
2020
Q2 | $9.63M | Buy |
110,259
+4,473
| +4% | +$386K | 0.04% | 200 |
|
|
2020
Q1 | $8.72M | Buy |
105,786
+34,173
| +48% | +$3.05M | 0.04% | 185 |
|
|
2019
Q4 | $6.78M | Buy |
71,613
+3,299
| +5% | +$296K | 0.03% | 259 |
|
|
2019
Q3 | $5.94M | Buy |
68,314
+1,022
| +2% | +$91.8K | 0.03% | 272 |
|
|
2019
Q2 | $6.14M | Sell |
67,292
-3,885
| -5% | -$329K | 0.03% | 253 |
|
|
2019
Q1 | $5.39M | Sell |
71,177
-48,772
| -41% | -$3.92M | 0.02% | 280 |
|
|
2018
Q4 | $9.22M | Sell |
119,949
-2,035
| -2% | -$158K | 0.05% | 192 |
|
|
2018
Q3 | $9.42M | Sell |
121,984
-1,600
| -1% | -$118K | 0.04% | 199 |
|
|
2018
Q2 | $8.37M | Buy |
123,584
+25,094
| +25% | +$1.73M | 0.04% | 212 |
|
|
2018
Q1 | $7.13M | Buy |
98,490
+60,835
| +162% | +$4.63M | 0.03% | 228 |
|
|
2017
Q4 | $2.83M | Buy |
37,655
+6,610
| +21% | +$499K | 0.01% | 258 |
|
|
2017
Q3 | $2.39M | Sell |
31,045
-84,523
| -73% | -$6.38M | 0.01% | 267 |
|
|
2017
Q2 | $8.64M | Buy |
115,568
+47,626
| +70% | +$3.38M | 0.04% | 219 |
|
|
2017
Q1 | $4.52M | Sell |
67,942
-38,033
| -36% | -$2.53M | 0.01% | 287 |
|
|
2016
Q4 | $6.92M | Buy |
105,975
+45,723
| +76% | +$2.97M | 0.02% | 190 |
|
|
2016
Q3 | $4.26M | Buy |
60,252
+15,818
| +36% | +$1.15M | 0.02% | 226 |
|
|
2016
Q2 | $3.29M | Buy |
44,434
+27,860
| +168% | +$1.92M | 0.01% | 250 |
|
|
2016
Q1 | $1.08M | Sell |
16,574
-10,824
| -40% | -$736K | 0.01% | 429 |
|
|
2015
Q4 | $2.11M | Buy |
27,398
+7,081
| +35% | +$563K | 0.01% | 324 |
|
|
2015
Q3 | $1.67M | Sell |
20,317
-4,593
| -18% | -$409K | 0.01% | 342 |
|
|
2015
Q2 | $2.19M | Buy |
24,910
+6,402
| +35% | +$587K | 0.01% | 321 |
|
|
2015
Q1 | $1.64M | Buy |
18,508
+12,354
| +201% | +$1.1M | 0.01% | 341 |
|
|
2014
Q4 | $511K | Sell |
6,154
-76
| -1% | -$6.3K | ﹤0.01% | 599 |
|
|
2014
Q3 | $525K | Buy |
6,230
+1,725
| +38% | +$140K | ﹤0.01% | 545 |
|
|
2014
Q2 | $365K | Buy |
4,505
+67
| +2% | +$5.27K | ﹤0.01% | 586 |
|
|
2014
Q1 | $338K | Sell |
4,438
-44
| -1% | -$3.21K | ﹤0.01% | 613 |
|
|
2013
Q4 | $323K | Buy |
4,482
+325
| +8% | +$22.6K | ﹤0.01% | 587 |
|
|
2013
Q3 | $286K | Buy |
4,157
+907
| +28% | +$60K | ﹤0.01% | 547 |
|
|
2013
Q2 | $206K | Buy |
+3,250
| New | +$211K | ﹤0.01% | 541 |
|
Other funds holding NVS
CIBC World Market's NVS Position: Q1 2026 in Review
CIBC World Market reduced its Novartis (NVS) stake by 84% in Q1 2026, selling an estimated $68.1M and leaving 84,313 shares worth $12.9M. The position accounts for 0.02% of the portfolio, ranked #337.
CIBC World Market first reported a position in NVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $208M in Q1 2025. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- CIBC World Market held 84,313 shares of Novartis worth $12.9M as of Q1 2026.
- CIBC World Market sold 444,250 Novartis shares in Q1 2026, an estimated $68.1M.
- Novartis made up 0.02% of CIBC World Market's portfolio in Q1 2026, its #337 holding.
- CIBC World Market first reported a position in Novartis in Q2 2013 and has held it in 52 quarters since.
- CIBC World Market's Novartis position peaked at $208M in Q1 2025.
- 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on CIBC World Market's 13F filing for Q1 2026, filed 14 May 2026.